Secondary Logo

Journal Logo

Articles by Jean-Daniel Lelièvre

Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study

Durier, Christine; Desaint, Corinne; Lelièvre, Jean-Daniel; More

AIDS. ., Post Acceptance: July 10, 2019

Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients

Thiébaut, Rodolphe; Hue, Sophie; Le Marec, Fabien; More

AIDS. 31(17):2355-2365, November 13, 2017.

Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers

Richert, Laura; Hue, Sophie; Hocini, Hakim; More

AIDS. 27(9):1421-1431, June 1st, 2013.

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

Salmon-Céron, Dominique; Durier, Christine; Desaint, Corinne; More

AIDS. 24(14):2211-2223, September 10th, 2010.